This inventor holds 20 USPTO granted patents and 16 published patent applications, plus 2 CIPO patents and 3 EPO patents, primarily in Immunotherapy Agents. Top assignees: Orionis Biosciences Bv, Orionis Biosciences, Inc., Vib Vzw. Active years: 2007-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Gent, BE (2009)
- Zwijnaarde, BE (2021 - 2022)
- Ghent, BE (2007 - 2023)
Company Filing History:
14 out of 25 
10 out of 17 
8 out of 238 
Years Active: 2007-2026
Areas of Expertise:
Title: **Lennart Zabeau: Innovator and Inventor in Biotherapeutics**
Introduction
Lennart Zabeau is a renowned inventor based in Ghent, Belgium, with a remarkable portfolio consisting of 13 patents. He has made significant contributions to the field of biotechnology, particularly in the development of novel therapeutic agents that target critical pathways in disease treatment.
Latest Patents
Among his latest innovations, Zabeau has developed binding agents targeting PD-1 and PD-L1. These agents hold promise as both diagnostic and therapeutic tools, with implications for treating various diseases. His patent work includes pharmaceutical compositions that incorporate these binding agents to enhance treatment efficacy. Additionally, he has crafted innovative CLEC9A-based chimeric protein complexes, which include an anti-Clec9A targeting moiety. These complexes showcase modified Fc domains and modified human IFNα, further establishing their potential as therapeutic agents and leading to new pharmaceutical compositions that aim to combat diverse diseases.
Career Highlights
Zabeau has shared his expertise with notable companies such as Orionis Biosciences BV and Orionis Biosciences, Inc. His career in these organizations has been marked by collaboration at the forefront of research and development in biomedicine, optimizing the use of innovative binding agents in therapeutic applications.
Collaborations
Throughout his career, Zabeau has collaborated with esteemed colleagues, including Jan Tavernier and Nikolai Kley. Their joint efforts in research and innovation have contributed to the successful development of groundbreaking biotherapeutic solutions that could benefit many patients.
Conclusion
Lennart Zabeau stands out as a prolific inventor whose work in binding agents and chimeric protein complexes continues to advance the field of biotechnology. His patents not only represent individual brilliance but also a commitment to improving therapeutic strategies in healthcare. With each innovation, Zabeau is paving the way for future advancements that may transform disease management and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile